Identification of serum glycobiomarkers for Hepatocellular Carcinoma using lectin microarrays
ObjectiveHepatocellular carcinoma (HCC) is the sixth most commonly occurring cancer and ranks third in mortality among all malignant tumors; as a result, HCC represents a major human health issue. Although aberrant glycosylation is clearly implicated in HCC, changes in serum immunoglobulin (Ig)G and...
Main Authors: | Yue Zhang, Sihua Zhang, Jianhua Liu, Yunli Zhang, Yanjie Liu, Shuang Shen, Fangfang Tian, Gaobo Yan, Yongqing Gao, Xiaosong Qin |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-10-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2022.973993/full |
Similar Items
-
Identification of Whole-Serum Glycobiomarkers for Colorectal Carcinoma Using Reverse-Phase Lectin Microarray
by: Tomas Bertok, et al.
Published: (2021-12-01) -
Retrospective screening of serum IgG glycosylation biomarker for primary Sjögren’s syndrome using lectin microarray
by: Siting Li, et al.
Published: (2023-02-01) -
Altered glycosylation profiles of serum IgG in Takayasu arteritis
by: Lingyu Liu, et al.
Published: (2023-02-01) -
Changes of Serum IgG Glycosylation Patterns in Primary Biliary Cholangitis Patients
by: Xiaoli Zeng, et al.
Published: (2021-06-01) -
IgG Glycosylation Profiling of Peripheral Artery Diseases with Lectin Microarray
by: Siting Li, et al.
Published: (2022-09-01)